Private Equity Firm LeapFrog Plans $100 Million Healthcare Investment in India

Global private equity firm LeapFrog Investments has announced plans to invest between $80 million and $100 million in India's healthcare sector over the next two years. The move aims to capitalize on the increasing demand for medical services across the country.

Government data indicates that India's healthcare sector was valued at approximately $180 billion in 2023 and is projected to expand to $320 billion by 2028. This growth is driven by expanding insurance coverage, greater adoption of diagnostics and preventive care, and high rates of chronic disease.

Data from advisory firm Grant Thornton Bharat and the Association of Healthcare Providers India shows that the healthcare and pharmaceutical sector recorded 594 mergers and acquisitions and private equity deals worth over $30 billion between 2022 and 2024. Recent major transactions in the market include KKR’s acquisition of Medicover Hospital’s India business for 1.2 billion euros ($1.4 billion).

Biju Mohandas, LeapFrog’s global head and partner for healthcare, stated that the firm is currently evaluating an investment in an asset-light, single-specialty healthcare provider. The London-based firm is also examining hospital investments, particularly those catering to patients outside major metropolitan areas, as well as specialty-care providers focused on maternal and child health, ophthalmology, and oncology.

“Our investment thesis is centred on two realities — growing insurance penetration and significant disposable income with the ability to afford quality healthcare,” Mohandas said.

LeapFrog’s existing portfolio in India includes diagnostics provider Redcliffe Labs and digital health platform Healthify. In addition to healthcare delivery, the firm is exploring potential opportunities in India’s pharmaceutical and medical equipment sectors.

The investments will be drawn from an $808 million fund and related co-investment vehicles, which provide the firm with more than $1 billion to deploy across Asia and Africa. While a significant portion of this capital has already been utilized for recent investments in the Philippines and Vietnam, Mohandas noted that substantial deployment opportunities remain in India over the next couple of years.

"LeapFrog's planned investment highlights the strong long-term fundamentals of India's healthcare market. With the sector projected to reach $320 billion by 2028, institutional investors are increasingly focusing on preventive care, diagnostics, and specialty providers outside major cities. As insurance penetration improves and disposable incomes rise, private equity deployment in asset-light and specialized care models will likely see sustained momentum over the coming years." — Dr. Shishir Gupta, Founder & CEO, StartupLanes